Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.

scientific article

Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00213-015-4128-2
P8608Fatcat IDrelease_ksh3xwgryzet3cv4oyikdodbei
P698PubMed publication ID26514555

P50authorJianjun YangQ57440988
Kenji HashimotoQ70911404
Ze-Min XieQ115617934
Guang-Fen ZhangQ115617937
P2093author name stringJing Wang
Ning Xu
Min Jia
Zhi-Qiang Zhou
Wen-Xue Liu
P2860cites workGABA and Glutamate Transporters in BrainQ21090476
The molecular neurobiology of depressionQ24656261
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionQ26859198
Antidepressant actions of ketamine: from molecular mechanisms to clinical practiceQ26995879
Glutamate uptakeQ28190140
Physiology and neurobiology of stress and adaptation: central role of the brainQ28235550
The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulationQ28239589
The mesolimbic dopamine reward circuit in depressionQ28304016
Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structuresQ28579755
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)Q29547223
A neurotrophic model for stress-related mood disordersQ29616291
Function and regulation of CREB family transcription factors in the nervous systemQ29619559
Neurobiology of depressionQ29619932
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesQ30471587
Glucocorticoids and hippocampal atrophy in neuropsychiatric disordersQ31811786
Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticityQ33583969
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's diseaseQ34065279
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.Q34330678
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.Q34382218
Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammationQ34460057
Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanismQ34467554
Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.Q34492381
Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist.Q34496197
Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.Q34621808
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connectionsQ34661281
Stress, depression, and neuroplasticity: a convergence of mechanismsQ34686632
Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposureQ34744471
Fates-shifted is an F-box protein that targets Bicoid for degradation and regulates developmental fate determination in Drosophila embryosQ34783457
Stress and plasticity in the limbic systemQ35570830
Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic systemQ35611041
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agentsQ35754079
Paeoniflorin improves menopause depression in ovariectomized rats under chronic unpredictable mild stress.Q35791946
Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depressionQ36279126
Astrocyte control of synaptic transmission and neurovascular coupling.Q36525563
Role of neurotrophic factors in depressionQ36627683
Stress, depression and hippocampal apoptosis.Q36638704
BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments.Q36726995
Gliogenesis and glial pathology in depressionQ36825936
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyondQ36899381
Regulation of neurogenesis and gliogenesis by stress and antidepressant treatmentQ37017934
Blockade of the GLT-1 Transporter in the Central Nucleus of the Amygdala Induces both Anxiety and Depressive-Like SymptomsQ37024834
Targeting of NMDA receptors in new treatments for schizophreniaQ38223276
Multistage drug effects of ketamine in the treatment of major depression.Q38248776
Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric DisordersQ38394074
Regional differences in brain-derived neurotrophic factor levels and dendritic spine density confer resilience to inescapable stressQ39272870
Sulfhydryl modification of cysteine mutants of a neuronal glutamate transporter reveals an inverse relationship between sodium dependent conformational changes and the glutamate-gated anion conductanceQ40378823
Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stressQ41722126
Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampusQ42490767
Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus.Q43892559
Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3betaQ46740453
Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment.Q46881170
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampusQ46989886
Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effectsQ47666769
Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder.Q47706465
Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administrationQ47851184
Therapeutic implications for NMDA receptors in mood disorders.Q47901451
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptorsQ48099473
Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.Q48129182
Hippocampal astrocytes are necessary for antidepressant treatment of learned helplessness ratsQ48155232
Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving ratsQ48176994
Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.Q48385750
Antidepressant-like effects of ceftriaxone in male C57BL/6J miceQ48438446
Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigineQ49039108
P433issue3
P921main subjectapoptotic processQ14599311
P304page(s)405-415
P577publication date2015-10-29
P1433published inPsychopharmacologyQ1422802
P1476titleRegulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression
P478volume233